Dr Hantel on Eligibility Criteria Associated With Racial/Ethnic Disparities in Clinical Trial ...
A study by Andrew Hantel, MD, and colleagues at Dana-Farber Cancer Institute and 6 other hospitals found that patients from minoritized populations with AML were eligible for 6.8% fewer clinical trials than Non-Hispanic White patients, highlighting the need for more inclusive trial designs.
Reference News
Dr Hantel on Eligibility Criteria Associated With Racial/Ethnic Disparities in Clinical Trial ...
A study by Andrew Hantel, MD, and colleagues at Dana-Farber Cancer Institute and 6 other hospitals found that patients from minoritized populations with AML were eligible for 6.8% fewer clinical trials than Non-Hispanic White patients, highlighting the need for more inclusive trial designs.